Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
| العنوان: | Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article |
|---|---|
| المؤلفون: | Emir Festic, Faeq R Kukhon |
| المصدر: | Medical Sciences Medical Sciences, Vol 9, Iss 34, p 34 (2021) |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | medicine.medical_specialty, community-acquired pneumonia, medicine.medical_treatment, Anti-Inflammatory Agents, Inhaled corticosteroids, Review, Lung injury, long-acting beta agonists, law.invention, 03 medical and health sciences, 0302 clinical medicine, Immune system, Randomized controlled trial, Community-acquired pneumonia, law, Adrenal Cortex Hormones, medicine, Humans, 030212 general & internal medicine, Intensive care medicine, Glucocorticoids, Adjuvants, Pharmaceutic, business.industry, Pneumonia, medicine.disease, systemic corticosteroids, Review article, respiratory tract diseases, Community-Acquired Infections, 030228 respiratory system, Medicine, inhaled corticosteroids, business, Adjuvant |
| الوصف: | Community-acquired pneumonia is still a major cause of morbidity and mortality worldwide. Since the inflammatory response induced by the immune system is often a major contributor to the lung injury, it becomes reasonable to assess the potential benefit of anti-inflammatory agents in treating community-acquired pneumonia. The role of corticosteroids as adjunct anti-inflammatory agents in treating community-acquired pneumonia is still controversial. Several studies have assessed the benefit of their use in patients with community-acquired pneumonia. In most of those studies, the route of corticosteroids administration was systemic. The aim of this article is to provide a concise review of the role of corticosteroids in treating community-acquired pneumonia when administered via inhalational route, with the potential benefit of avoiding systemic side effects of corticosteroids while exerting the same anti-inflammatory effects on the lungs. Conclusion: the use of inhaled corticosteroids may be of benefit in certain patient subsets with community-acquired pneumonia. Further randomized controlled trials are needed for better determination of such patient subsets. |
| تدمد: | 2076-3271 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf73af77486d243c4b62a581c65e9446 https://pubmed.ncbi.nlm.nih.gov/34071031 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....bf73af77486d243c4b62a581c65e9446 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 20763271 |
|---|